Huaren Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 403.24 million compared to CNY 385.49 million a year ago. Revenue was CNY 403.24 million compared to CNY 385.49 million a year ago.

Net income was CNY 41.1 million compared to CNY 25.04 million a year ago. Basic earnings per share from continuing operations was CNY 0.0348 compared to CNY 0.0212 a year ago. Diluted earnings per share from continuing operations was CNY 0.0348 compared to CNY 0.0212 a year ago.